
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Polypharmacology of clinical sodium glucose co‐transport protein 2 inhibitors and relationship to suspected adverse drug reactions
Karanveer Singh Matharu, Kiran Chana, Charles J. Ferro, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 15
Karanveer Singh Matharu, Kiran Chana, Charles J. Ferro, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 15
Showing 15 citing articles:
The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors
Meiyuan Dong, Song Wen, Ligang Zhou
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 2583-2597
Open Access | Times Cited: 44
Meiyuan Dong, Song Wen, Ligang Zhou
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 2583-2597
Open Access | Times Cited: 44
Angiotensin II receptor blockers (ARBs) and manufacturing contamination: A retrospective National Register Study into suspected associated adverse drug reactions
Hamisha Salim, Alan M. Jones
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 11, pp. 4812-4827
Open Access | Times Cited: 14
Hamisha Salim, Alan M. Jones
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 11, pp. 4812-4827
Open Access | Times Cited: 14
Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl‐peptidase IV inhibitors (DPP4i ): Can polypharmacology help explain?
Lauren Jones, Alan M. Jones
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 13
Lauren Jones, Alan M. Jones
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 13
United Kingdom National Register Study of Anti-Epileptic Medications: Suspected Foetal Congenital And Pregnancy-Associated Side Effects
Benjamin Phillips, I. L. Evans, Victoria Skerrett, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Benjamin Phillips, I. L. Evans, Victoria Skerrett, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
The Relationship Between Suspected Adverse Drug Reactions Of HMG-Coa Reductase Inhibitors And Polypharmacology Using A National Registry Approach
Hasan Yousaf, Alan M. Jones
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Hasan Yousaf, Alan M. Jones
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The latest emerging drugs for the treatment of diabetic cardiomyopathy
Minghao Li, Lin Liu, Chunyu Zhang, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 641-654
Closed Access | Times Cited: 1
Minghao Li, Lin Liu, Chunyu Zhang, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 641-654
Closed Access | Times Cited: 1
Suspected Adverse Drug Reactions Associated with Leukotriene Receptor Antagonists Versus First Line Asthma Medications: A National Registry-Pharmacology Approach
Mohammed Khan, Christine Hirsch, Alan M. Jones
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Mohammed Khan, Christine Hirsch, Alan M. Jones
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Associations between Suspected Adverse Drug Reactions of HMG-CoA Reductase Inhibitors and Polypharmacology Using a National Registry Approach
Hasan Yousaf, Alan M. Jones
Pharmacoepidemiology (2024) Vol. 3, Iss. 3, pp. 241-251
Open Access | Times Cited: 1
Hasan Yousaf, Alan M. Jones
Pharmacoepidemiology (2024) Vol. 3, Iss. 3, pp. 241-251
Open Access | Times Cited: 1
Adverse events and drug–drug interactions of sodium glucose co-transporter 2 inhibitors in patients treated for heart failure
Claudia Stöllberger, Josef Finsterer, Birke Schneider
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 11, pp. 803-816
Closed Access | Times Cited: 2
Claudia Stöllberger, Josef Finsterer, Birke Schneider
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 11, pp. 803-816
Closed Access | Times Cited: 2
Managing Patients on SGLT2 Inhibitors in Primary Care
Javed Butler, John E. Anderson
JACC Heart Failure (2024) Vol. 12, Iss. 6, pp. S7-S9
Closed Access
Javed Butler, John E. Anderson
JACC Heart Failure (2024) Vol. 12, Iss. 6, pp. S7-S9
Closed Access
Standardized Chromatographic and Computational Approaches for Lipophilicity Analysis of Five Gliflozin Antidiabetic Drugs in Relation to Their Biological Activity
Anna Gumieniczek, Anna Berecka, M. W. Dul, et al.
Molecules (2024) Vol. 30, Iss. 1, pp. 115-115
Open Access
Anna Gumieniczek, Anna Berecka, M. W. Dul, et al.
Molecules (2024) Vol. 30, Iss. 1, pp. 115-115
Open Access
The Interplay Between Molecular Architecture, Pharmacology, and Suspected Adverse Drug Reactions Associated with Non-Steroidal Androgen Antagonists in The United Kingdom
S. Dhillon, Albert A. Antolín, Alan M. Jones
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
S. Dhillon, Albert A. Antolín, Alan M. Jones
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Empagliflozin Attenuates High-Glucose-Induced Astrocyte Activation and Inflammation via NF-κB Pathway
Dong Hee Kim, Min Jin Lee, Dasol Kang, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 12417-12427
Open Access
Dong Hee Kim, Min Jin Lee, Dasol Kang, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 12417-12427
Open Access
Suspected Adverse Drug Reactions of the Type 2 Antidiabetic Drug Class Dipeptidyl-Peptidase IV inhibitors (DPP4i): Can polypharmacology help explain?
Lauren Jones, Alan M. Jones
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Lauren Jones, Alan M. Jones
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2